BIOMAT Database Logo BIOMAT Database Logo

[Baclofen toxicity during intermittent renal dialysis (author's transl)]. 1981

S Seyfert, and D Kraft, and K Wagner

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004569 Electroencephalography Recording of electric currents developed in the brain by means of electrodes applied to the scalp, to the surface of the brain, or placed within the substance of the brain. EEG,Electroencephalogram,Electroencephalograms
D005260 Female Females
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001418 Baclofen A GAMMA-AMINOBUTYRIC ACID derivative that is a specific agonist of GABA-B RECEPTORS. It is used in the treatment of MUSCLE SPASTICITY, especially that due to SPINAL CORD INJURIES. Its therapeutic effects result from actions at spinal and supraspinal sites, generally the reduction of excitatory transmission. Baclophen,Chlorophenyl GABA,Apo-Baclofen,Atrofen,Ba-34,647,Ba-34647,Baclofen AWD,Baclofène-Irex,Baclospas,CIBA-34,647-BA,Clofen,Gen-Baclofen,Genpharm,Lebic,Lioresal,Liorésal,Nu-Baclo,PCP-GABA,PMS-Baclofen,beta-(Aminomethyl)-4-chlorobenzenepropanoic Acid,beta-(p-Chlorophenyl)-gamma-aminobutyric Acid,AWD, Baclofen,Apo Baclofen,ApoBaclofen,Ba34,647,Ba34647,Baclofène Irex,BaclofèneIrex,CIBA34,647BA,GABA, Chlorophenyl,Gen Baclofen,GenBaclofen,Nu Baclo,NuBaclo,PMS Baclofen,PMSBaclofen
D019966 Substance-Related Disorders Disorders related to substance use or abuse. Chemical Dependence,Drug Abuse,Drug Addiction,Drug Dependence,Drug Habituation,Drug Use Disorder,Drug Use Disorders,Organic Mental Disorders, Substance-Induced,Substance Abuse,Substance Dependence,Substance Related Disorder,Substance Use,Substance Use Disorder,Substance Use Disorders,Prescription Drug Abuse,Substance Addiction,Abuse, Drug,Abuse, Prescription Drug,Abuse, Substance,Addiction, Drug,Addiction, Substance,Chemical Dependences,Dependence, Chemical,Dependence, Drug,Dependence, Substance,Dependences, Chemical,Disorder, Drug Use,Disorder, Substance Related,Disorder, Substance Use,Disorders, Substance Related,Drug Abuse, Prescription,Habituation, Drug,Organic Mental Disorders, Substance Induced,Related Disorder, Substance,Related Disorders, Substance,Substance Abuses,Substance Uses,Use, Substance

Related Publications

S Seyfert, and D Kraft, and K Wagner
[Spontaneous colonic perforation during chronic intermittent peritoneal dialysis (author's transl)].
October 1981, Deutsche medizinische Wochenschrift (1946),
S Seyfert, and D Kraft, and K Wagner
[Radiological demonstration of renal osteopathy during chronic dialysis (author's transl)].
January 1974, Deutsche medizinische Wochenschrift (1946),
S Seyfert, and D Kraft, and K Wagner
[Morbidity during regular dialysis treatment and after renal transplantation (author's transl)].
March 1979, Wiener klinische Wochenschrift,
S Seyfert, and D Kraft, and K Wagner
[Renal toxicity of antibiotics (author's transl)].
September 1973, Munchener medizinische Wochenschrift (1950),
S Seyfert, and D Kraft, and K Wagner
[Analysis of toxicity in intermittent ethambutol-medication (author's transl)].
July 1973, Klinische Monatsblatter fur Augenheilkunde,
S Seyfert, and D Kraft, and K Wagner
[Aminoglycosides, renal toxicity and enzymes (author's transl)].
November 1978, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
S Seyfert, and D Kraft, and K Wagner
Baclofen Toxicity in a Patient with End-stage Renal Disease on Maintenance Dialysis.
January 2023, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia,
S Seyfert, and D Kraft, and K Wagner
[Intermittent calcic renal diabetes presenting as pneumomediastinum (author's transl)].
January 1982, Le Poumon et le coeur,
S Seyfert, and D Kraft, and K Wagner
[Hepatic and renal toxicity of enflurane (author's transl)].
January 1980, Anesthesie, analgesie, reanimation,
S Seyfert, and D Kraft, and K Wagner
[Dialysis and renal transplantation in Switzerland 1975 (author's transl)].
April 1978, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
Copied contents to your clipboard!